Summary
To investigate the effect of preceding naloxone injection into the third cerebroventricle or acute subdiaphragmatic vagotomy on the gastric acid secretion inhibited by the somatostatin analogue octreotide given by intracerebroventricular (icv) injection. The third ventricles were cannulated in male Wistar rats anesthetized with sodium pentobarbital. One week later, acute gastric lumen perfusion was carried out. The gastric perfusion samples were collected every 10 min and were titrated by 0.01 mol/L NaOH to neuter. On the basis of subcutaneous injection of pentagastrin (G-5, 160 μ g/kg), icv injection of physiological saline (group A, n=20), icv injection of octreotide (0.05 μ g) (group B, n=20), icv injection of naloxone (2.5 μ g)+octreotide (0.05 μ g) (group C, n=20), acute subdiaphragmatic vagotomy+ icv injection of physiological saline (group D, n=20), or acute subdiaphragmatic vagotomy+icv injection of octreotide (0.05 μ g) (group E, n=20) were conducted. Before and after icv injection, 1-h total acid output (TAO) was determined and compared. The experimental data were expressed in change rate (%) of TAO. The change rates (%) of TAO were 4.60% in group A, −20.35% in group B, −18.06% in group C, 5.01% in group D and −21.59% in group E, respectively. Comparison of group B or C versus group A showed that P<0.01 and comparison between the group E versus group D showed that P<0.01. Whereas the differences between group C and group B, group E and group B were not statistically significant (P>0.05 for all). The results indicate that the central inhibition of gastric acid secretion by octreotide may not be mediated by the endogenous opiate substance or its receptor and the peripheral pathway for icv injection of octreotide to suppress gastric acid secretion is via extra-vagus route.
Similar content being viewed by others
References
Pawlikoswski M, Melen-Mucha G. Somatostatin analogs—from new molecules to new applications. Curr Opin Pharmacol, 2004,4(6):608–613
Gao F, Lu G Q. Effect of injection of SMS201–995 into third ventricle on the gastrin-induced gastric acid secretion in rats. Acta Univ Med Tongji, 1998;27(Suppl 2):168–170
Wang Z L, Lu G Q. Effect of intraventricular administration of histamine and its receptor agonists on pentagastrin-induced gastric acid secretion. Acta Physiol Sin, 1992, 44(3):261–268
Yoneda M, Tache Y. SMS 201–995-induced stimulation of gastric acid secretion via the dorsal vagal complex and inhibition via the hypothalamus in anaesthetized rats. Br J Pharmacol 1995,116(4):2303–2309
5 Yoneda M, Raybould H, Tache Y. Central action of somatostatin analog, SMS 201–995, to stimulate gastric acid secretion in rats. Peptides, 1991,12(3):401–406
Shiraishi T. Hypothalamic control of gastric acid secretion. Brain Res Bull, 1988,20(6):791–797
Martinez V, Coy D H, Lioyd K C et al. Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. Eur J Pharmacol, 1996;296(2):153–160
Tache Y, Goto Y, Gunion M et al. Inhibition of gastric acid secretion in rats and in dogs by corticotropin-releasing factor. Gastroenterology, 1984,86(2):281–286
Srikant C B, Patel Y C. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors. Endocrinology, 1984, 115(3):990–995
Reichlin S. Somatostatin. N Engl J Med 1983;309(25):1556–1563
Chaikof L, Janke W H, Pesaros P C et al. Effects of prednisone and corticotropin on gastric secretion. Experiments in Heidenhain pouch dogs. Arch Surg, 1991;83:32–41
Brown M R, Revier C, Vale W. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. Endocrinology, 1984;5:1546–1549
13 Morley J E, Levine A S, Silvis S E. Central regulation of gastric acid secretion: the role of neuropeptides. Life Sci, 1982,5:399–410
Somogyi P, Hodgson A J, Smith A D et al. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin-or cholecystokinin-immunoreactive material. J Neurosci, 1984,10:2590–2603
Gothert M. Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones. Nature, 1980,5786:86–88
Yu Z W, Wu R. The second stimulatory pathway of gastric acid secretion—sympathetic nervous system. Prog Physiol Sci, 1984,4:325–328
Chiba T, Yamada T. Gut somatostatin. In: Walsh JH; Dockray GJ, eds. Gut peptides. New York: Raven Press Ltd, 1994.123–145.
Author information
Authors and Affiliations
Additional information
GAO Feng, male, born in 1962, Associate Professor
This work was supported by Returning Overseas Scholar Science Study Foundation, the Education Ministry of China (No. 2005383).
Rights and permissions
About this article
Cite this article
Gao, F., Hu, X. & Chen, D. Naloxone or vagotomy does not influence centrally octreotide-induced inhibition of gastric acid secretion in rats. J. Huazhong Univ. Sc. Technol. 26, 432–435 (2006). https://doi.org/10.1007/s11596-006-0414-x
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-006-0414-x